BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29066258)

  • 1. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
    Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
    Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication.
    Di Capite S; Upthegrove R; Mallikarjun P
    Early Interv Psychiatry; 2018 Oct; 12(5):893-899. PubMed ID: 27734591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
    Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
    Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
    Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
    CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of second-generation antipsychotic discontinuation in first-episode psychosis.
    Miller BJ
    J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
    Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
    Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis.
    Thompson A; Singh S; Birchwood M
    Early Interv Psychiatry; 2016 Aug; 10(4):355-61. PubMed ID: 25962446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
    Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
    Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of hospitalisation and recovery following full antipsychotic discontinuation in first episode psychosis. A naturalistic retrospective cohort study.
    Wilson M; Harris M; Pereira M; Buckle J; Forshall E; Murphy T; Thompson A; Kavanagh G; Whale R
    Schizophr Res; 2023 Nov; 261():269-274. PubMed ID: 37862826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
    Landolt K; Rössler W; Ajdacic-Gross V; Derks EM; Libiger J; Kahn RS; Fleischhacker WW;
    Schizophr Res; 2016 Apr; 172(1-3):145-51. PubMed ID: 26922655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis.
    Kishi T; Ikuta T; Matsui Y; Inada K; Matsuda Y; Mishima K; Iwata N
    Psychol Med; 2019 Apr; 49(5):772-779. PubMed ID: 29909790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong.
    Hui CL; Tang JY; Leung CM; Wong GH; Chang WC; Chan SK; Lee EH; Chen EY
    Aust N Z J Psychiatry; 2013 Aug; 47(8):746-53. PubMed ID: 23612934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
    Zipursky RB; Menezes NM; Streiner DL
    Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
    Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.
    Caseiro O; Pérez-Iglesias R; Mata I; Martínez-Garcia O; Pelayo-Terán JM; Tabares-Seisdedos R; Ortiz-García de la Foz V; Vázquez-Barquero JL; Crespo-Facorro B
    J Psychiatr Res; 2012 Aug; 46(8):1099-105. PubMed ID: 22721546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting psychotic relapse following randomised discontinuation of paliperidone in individuals with schizophrenia or schizoaffective disorder: an individual participant data analysis.
    Brandt L; Ritter K; Schneider-Thoma J; Siafis S; Montag C; Ayrilmaz H; Bermpohl F; Hasan A; Heinz A; Leucht S; Gutwinski S; Stuke H
    Lancet Psychiatry; 2023 Mar; 10(3):184-196. PubMed ID: 36804071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.
    Chan KK; Chin QP; Tang JY; Longenecker J; Hui CL; Chiu CP; Lam MM; Wong GH; Chen EY
    Early Interv Psychiatry; 2011 Nov; 5(4):324-34. PubMed ID: 21521490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
    Hui CLM; Honer WG; Lee EHM; Chang WC; Chan SKW; Chen ESM; Pang EPF; Lui SSY; Chung DWS; Yeung WS; Ng RMK; Lo WTL; Jones PB; Sham P; Chen EYH
    Lancet Psychiatry; 2018 May; 5(5):432-442. PubMed ID: 29551618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
    Conus P; Cotton SM; Francey SM; O'Donoghue B; Schimmelmann BG; McGorry PD; Lambert M
    Schizophr Res; 2017 Jul; 185():130-136. PubMed ID: 28065484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.